Funding for this research was provided by:
Universität Ulm
Article History
Received: 6 July 2025
Revised: 18 October 2025
Accepted: 24 December 2025
First Online: 9 January 2026
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the University of Ulm (264/24). The authors confirm that the ethical guidelines of the journal were adhered to and that approval was obtained from the appropriate ethics committee. Verbal informed consent was obtained from the participants and approved by the Ethics Committee. In addition, written consent for publication of identifying information and accompanying images was obtained.
: The retrospective study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the University of Ulm (264/24).
: The authors affirm that human research participants provided informed consent for publication of the images.
: All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript. Melih Parlak and Jens Ulrich Werner received speaker fees from Bayer and Novartis. Prof. Dr. Armin Wolf received research grants and study fees from Allergan, Boehringer Ingelheim, Bayer, Alimera, Novartis, Oertli and Roche and consulting honoraria and travel fees from Alimera, Allergan, Bayer, Boehringer Ingelheim, Novartis, Oertli, Roche and Zeiss. For the remaining authors none conflict of interests or fundings were declared.